BECTON DICKINSON AND CO (NYSE:BDX) Shares Slide on Q4 Revenue Miss Despite EPS Meet

BECTON DICKINSON AND CO (NYSE:BDX) reported fiscal fourth quarter 2025 earnings that presented a mixed picture for investors, with the medical technology company delivering solid bottom-line performance while falling slightly short on revenue expectations. The earnings release, covering the period ending September 30, 2025, has triggered a notable negative reaction in pre-market trading.

Earnings and Revenue Versus Estimates

The company's performance against analyst forecasts reveals the primary driver behind the current market sentiment.

• Q4 2025 Revenue: The company reported $5.89 billion, which came in below the analyst consensus estimate of approximately $5.96 billion.
• Q4 2025 Adjusted EPS: BD reported non-GAAP earnings per share of $3.96, effectively meeting the precise analyst estimate of $3.9601.

While the company demonstrated strong cost control and profitability by hitting its earnings target precisely, the revenue miss appears to be the focal point for investors in early trading. The ability to meet earnings expectations despite a top-line shortfall suggests operational efficiency, but the market is often forward-looking and may be concerned about growth momentum.

Market Reaction

The immediate market response to the earnings report has been decisively negative. In pre-market trading, BDX shares are down approximately 4.8%. This sharp decline indicates that investors are weighing the revenue miss more heavily than the earnings meet. The stock's recent performance had been relatively stable, with minor declines over the past week and month, but the earnings release has clearly introduced a new wave of selling pressure.

Press Release Summary

Beyond the headline numbers, the company's announcement highlighted several key operational and financial achievements for the full fiscal year 2025. BD reported fourth-quarter revenue growth of 8.3% on a reported basis, or 7.0% on a currency-neutral basis. The press release also emphasized the company's consistent commitment to shareholder returns, noting that its Board of Directors has increased the dividend for the 54th consecutive year, declaring a quarterly dividend of $1.05 per common share. This underscores the company's financial stability and long-term focus on returning capital to shareholders, even amidst quarterly fluctuations.

Looking Ahead

The financial community has already established expectations for BD's future performance. For the upcoming first quarter of fiscal 2026, analysts are projecting sales of $5.44 billion. Looking at the full 2026 fiscal year, the sales estimate stands at $23.02 billion. The company's own forward-looking guidance, if provided in the detailed earnings call or report, will be critical for investors to compare against these benchmarks and assess whether the Q4 revenue shortfall was an anomaly or part of a broader trend.

For a detailed breakdown of historical earnings, future estimates, and analyst projections, review the complete data available on the BDX earnings and estimates page.

Disclaimer: This article is for informational purposes only and does not constitute financial advice, a recommendation, or an offer or solicitation to buy or sell any securities. The content presented is based on data believed to be reliable but is not guaranteed. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions.